Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels - Archive ouverte HAL Access content directly
Journal Articles Journal of Hepatology Year : 2022

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

Milan Sonneveld
Shao-Ming Chiu
  • Function : Author
Jun Yong Park
  • Function : Author
Sylvia Brakenhoff
  • Function : Author
Apichat Kaewdech
  • Function : Author
Wai-Kay Seto
  • Function : Author
Yasuhito Tanaka
  • Function : Author
Ivana Carey
  • Function : Author
Margarita Papatheodoridi
  • Function : Author
Florian van Bömmel
  • Function : Author
Thomas Berg
  • Function : Author
Sang Hoon Ahn
  • Function : Author
George Dalekos
  • Function : Author
Nicole Erler
  • Function : Author
Heiner Wedemeyer
  • Function : Author
Markus Cornberg
  • Function : Author
Man-Fung Yuen
  • Function : Author
Kosh Agarwal
  • Function : Author
Andre Boonstra
  • Function : Author
Maria Buti
  • Function : Author
Teerha Piratvisuth
  • Function : Author
George Papatheodoridis
  • Function : Author
Chien-Hung Chen
  • Function : Author
Benjamin Maasoumy
  • Function : Author

Dates and versions

hal-04013069 , version 1 (03-03-2023)

Identifiers

Cite

Milan Sonneveld, Shao-Ming Chiu, Jun Yong Park, Sylvia Brakenhoff, Apichat Kaewdech, et al.. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels. Journal of Hepatology, 2022, 76 (5), pp.1042-1050. ⟨10.1016/j.jhep.2022.01.007⟩. ⟨hal-04013069⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More